Search - tctmd.com

Displaying 181 - 200 of 573

Sort: Relevancy | Date

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

October 16, 2017

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

News Daily News

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

October 13, 2017

Sky-High US Obesity Rates Aren’t Coming Down

News Daily News

Sky-High US Obesity Rates Aren’t Coming Down

October 13, 2017

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

October 12, 2017

Merck Calls Quits on CETP Inhibitor Anacetrapib

News Daily News

Merck Calls Quits on CETP Inhibitor Anacetrapib

Michael O'Riordan

October 12, 2017

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

October 10, 2017

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

October 06, 2017

Generic ARBs Linked to Increased Adverse Events

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

News Daily News

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

October 04, 2017

Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death

News Daily News

Switching to E-Cigarettes From Tobacco Could Drastically Curb Premature Death

October 04, 2017

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

News Daily News

Modified Risk Score for ED Chest Pain Patients Reduces Hospital Stays, Lowers Costs

Michael O'Riordan

October 03, 2017

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

News Daily News

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

October 02, 2017

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

News Daily News

‘A Healthy Brexit’? How a Split From EU Could Affect UK Health System

Yael L. Maxwell

October 02, 2017

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

Women Receive Less Aggressive CABG Compared With Men

News Daily News

Women Receive Less Aggressive CABG Compared With Men

Yael L. Maxwell

September 29, 2017

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.